Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference

Media type: E-Article

Title: Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference

Contributor: Rubino, Marta; Monda, Emanuele; Caiazza, Martina; Palmiero, Giuseppe; Lioncino, Michele; Cirillo, Annapaola; Fusco, Adelaide; Verrillo, Federica; Perna, Alessia; Diana, Gaetano; Amodio, Federica; Cesaro, Arturo; Duro, Giovanni; Sarubbi, Berardo; Russo, Maria Giovanna; Calabrò, Paolo; Limongelli, Giuseppe

imprint: MDPI AG, 2022

Language: English

DOI: 10.3390/cardiogenetics12010010

ISSN: 2035-8148

Keywords: General Materials Science

Origination:

Footnote:

Description: Fabry disease (FD) is a multiorgan disease, which can potentially affect any organ or tissue, with the heart, kidneys, and central nervous system representing the major disease targets. FD can be suspected based on the presence of specific red flags, and the subsequent evaluation of the α-Gal A activity and GLA sequencing, are required to confirm the diagnosis, to evaluate the presence of amenable GLA mutation, and to perform a cascade program screening in family members. An early diagnosis is required to start an etiological treatment and to prevent irreversible organ damage. Here, we describe a case of a 37-years-old patient, with a surgically repaired congenital heart defect in his childhood, who had a late diagnosis of FD based on the clinical history and targeted genetic evaluation. This case highlights the importance to perform a correct phenotyping and definite diagnosis of FD, to start an early and appropriate treatment in the index patient, and a cascade clinical and genetic screening to identify other family members at risk, which may benefit from specific treatment and/or a close follow-up.

Access State: Open Access

Search in field:

Recently searched for: